Archer Exploration has announced that it has entered into a legally binding Material Transfer Agreement (“MTA”) with a leading German biotechnology company, regarding Archer’s graphene-based biosensor development activities with The University of Adelaide ARC Graphene Hub.
The Agreement involves the transfer of materials between Archer and the Partner for use in the development of electrochemical biosensors for the semi-quantitative detection of disease state markers. The materials to be used include those held in the inventory of the Partner (e.g. infectious disease antigens, antibodies, disease state sera, coupling and assay reagents) and materials in the inventory of Archer’s wholly owned subsidiary Carbon Allotropes (e.g. graphene, ink formulations, and printed graphene electrodes).